Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

biote (BTMD) Payables: 2021-2024

Historic Payables for biote (BTMD) over the last 4 years, with FY2024 value amounting to $5.8 million.

  • biote's Payables fell 34.29% to $4.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.4 million, marking a year-over-year decrease of 34.29%. This contributed to the annual value of $5.8 million for FY2024, which is 3990.37% up from last year.
  • Latest data reveals that biote reported Payables of $5.8 million as of FY2024, which was up 3990.37% from $4.2 million recorded in FY2023.
  • biote's 5-year Payables high stood at $5.8 million for FY2024, and its period low was $4.1 million during FY2022.
  • Its 4-year average for Payables is $4.6 million, with a median of $4.3 million in 2021.
  • In the last 5 years, biote's Payables tumbled by 544.95% in 2022 and then surged by 3990.37% in 2024.
  • Annual analysis of 4 years shows biote's Payables stood at $4.3 million in 2021, then decreased by 5.45% to $4.1 million in 2022, then grew by 1.05% to $4.2 million in 2023, then surged by 39.9% to $5.8 million in 2024.
  • Its last three reported values are $5.8 million in FY2024, $4.2 million for FY2023, and $4.1 million during FY2022.